Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
bioRxiv (2020) - Comments
doi: 10.1101/2020.09.03.20187112 

Leticia R. Cruz, Idania Baladron, Aliusha Rittoles, Pablo A. Diaz, Carmen Valenzuela, Raul Santana, Maria M. Vazquez, Ariadna Garcia, Deyli Chacon, Delvin Thompson, Gustavo Perera, Ariel Gonzalez, Rafael Reyes, Loida Torres, Jesus Perez, Yania Valido, Ralysmay Rodriguez, Dania M. Vazquez, Mauro Rosales, Ailyn C. Ramon